Leerink Partnrs Has Strong Forecast for ISRG FY2025 Earnings

Key Points

• Leerink Partners has raised its FY2025 EPS estimates for Intuitive Surgical from $6.25 to $6.56, reflecting an increase in confidence in the company’s earnings potential.
• Intuitive Surgical reported $2.19 EPS in its latest earnings, exceeding analysts' expectations of $1.93, with revenues up by 21.4% year-over-year.
• The stock currently has a consensus rating of "Moderate Buy" with a target price of $592.05, according to MarketBeat.com, with a significant number of analysts issuing buy ratings.

Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) - Research analysts at Leerink Partnrs raised their FY2025 EPS estimates for shares of Intuitive Surgical in a note issued to investors on Wednesday, July 23rd. Leerink Partnrs analyst M. Kratky now anticipates that the medical equipment provider will post earnings per share of $6.56 for the year, up from their prior forecast of $6.25. The consensus estimate for Intuitive Surgical's current full-year earnings is $6.43 per share. Leerink Partnrs also issued estimates for Intuitive Surgical's FY2026 earnings at $7.67 EPS.

Other research analysts also recently issued research reports about the stock. Robert W. Baird cut their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Citigroup reiterated a "buy" rating and issued a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Evercore ISI lifted their target price on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a report on Tuesday, July 8th. Barclays dropped their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Finally, Piper Sandler reiterated an "overweight" rating and issued a $595.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. One analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $592.05.

Intuitive Surgical Trading Up 1.5%

Intuitive Surgical stock opened at $495.86 on Monday. The company has a market capitalization of $177.76 billion, a P/E ratio of 69.16, a P/E/G ratio of 5.20 and a beta of 1.64. The firm's fifty day simple moving average is $529.86 and its 200-day simple moving average is $535.01. Intuitive Surgical has a 1-year low of $425.00 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company's revenue for the quarter was up 21.4% on a year-over-year basis. During the same quarter last year, the business posted $1.78 EPS.

Insider Activity

In other news, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the sale, the senior vice president directly owned 907 shares in the company, valued at approximately $510,740.77. The trade was a 19.23% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director owned 6,371 shares in the company, valued at approximately $3,312,920. This trade represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 7,610 shares of company stock worth $3,858,340. Corporate insiders own 0.70% of the company's stock.

Institutional Trading of Intuitive Surgical

Several institutional investors have recently made changes to their positions in the business. Hurley Capital LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at about $28,000. Parvin Asset Management LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at about $26,000. Chilton Capital Management LLC boosted its position in Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after buying an additional 43 shares in the last quarter. Global Financial Private Client LLC boosted its position in Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after buying an additional 38 shares in the last quarter. Finally, Elite Financial Inc. acquired a new position in Intuitive Surgical in the first quarter valued at about $26,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.